rs541915908
Positions:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_181840.1(KCNK18):c.361dupT(p.Tyr121fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00143 in 1,613,916 control chromosomes in the GnomAD database, including 40 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00077 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 39 hom. )
Consequence
KCNK18
NM_181840.1 frameshift
NM_181840.1 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.17
Genes affected
KCNK18 (HGNC:19439): (potassium two pore domain channel subfamily K member 18) Potassium channels play a role in many cellular processes including maintenance of the action potential, muscle contraction, hormone secretion, osmotic regulation, and ion flow. This gene encodes a member of the superfamily of potassium channel proteins containing two pore-forming P domains and the encoded protein functions as an outward rectifying potassium channel. A mutation in this gene has been found to be associated with migraine with aura.[provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000775 (118/152258) while in subpopulation SAS AF= 0.0195 (94/4812). AF 95% confidence interval is 0.0163. There are 1 homozygotes in gnomad4. There are 89 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 118 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNK18 | NM_181840.1 | c.361dupT | p.Tyr121fs | frameshift_variant | 3/3 | ENST00000334549.1 | NP_862823.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNK18 | ENST00000334549.1 | c.361dupT | p.Tyr121fs | frameshift_variant | 3/3 | 1 | NM_181840.1 | ENSP00000334650.1 |
Frequencies
GnomAD3 genomes AF: 0.000762 AC: 116AN: 152140Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
116
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00263 AC: 659AN: 250950Hom.: 12 AF XY: 0.00345 AC XY: 468AN XY: 135774
GnomAD3 exomes
AF:
AC:
659
AN:
250950
Hom.:
AF XY:
AC XY:
468
AN XY:
135774
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00150 AC: 2188AN: 1461658Hom.: 39 Cov.: 33 AF XY: 0.00207 AC XY: 1506AN XY: 727146
GnomAD4 exome
AF:
AC:
2188
AN:
1461658
Hom.:
Cov.:
33
AF XY:
AC XY:
1506
AN XY:
727146
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000775 AC: 118AN: 152258Hom.: 1 Cov.: 32 AF XY: 0.00120 AC XY: 89AN XY: 74456
GnomAD4 genome
AF:
AC:
118
AN:
152258
Hom.:
Cov.:
32
AF XY:
AC XY:
89
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
55
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Migraine, with or without aura, susceptibility to, 13 Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | May 21, 2020 | A heterozygous duplication variant was identified, NM_181840.1(KCNK18):c.361dupT in exon 3 of 3 of the KCNK18 gene. This duplication is predicted to cause a frameshift from amino acid position 121 introducing a stop codon 44 residues downstream, NP_862823.1(KCNK18):p.(Tyr121Leufs*44), resulting in a truncated protein. The variant is present in the gnomAD population database at a frequency of 1.9% (561 heterozygotes, 11 homozygotes) in the South Asian subpopulation. It has been previously reported as likely pathogenic (ClinVar) and with questionable disease contribution (Gardiner, 2016). In addition, functional studies show that this variant produces a new isoform capable of repressing TREK1 and TREK2, however the mechanism of this activity is also questionable (Royal, P. et al. (2019)). There are no other downstream variants predicted to cause a truncated protein that have been reported as pathogenic in individuals with this condition (ClinVar). Based on information available at the time of curation, this variant has been classified as a VARIANT of UNCERTAIN SIGNIFICANCE (VUS). - |
Likely pathogenic, criteria provided, single submitter | reference population | Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center | Mar 18, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 26, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at